Phenotypic variability in ALS-FTD and effect on survival

OBJECTIVETo determine if survival and cognitive profile is affected by initial presentation in amyotrophic lateral sclerosis–frontotemporal dementia (ALS-FTD) (motor vs cognitive), we compared survival patterns in ALS-FTD based on initial phenotypic presentation and their cognitive profile compared...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2020-05, Vol.94 (19), p.e2005-e2013
Hauptverfasser: Ahmed, Rebekah M., Devenney, Emma M., Strikwerda-Brown, Cherie, Hodges, John R., Piguet, Olivier, Kiernan, Matthew C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e2013
container_issue 19
container_start_page e2005
container_title Neurology
container_volume 94
creator Ahmed, Rebekah M.
Devenney, Emma M.
Strikwerda-Brown, Cherie
Hodges, John R.
Piguet, Olivier
Kiernan, Matthew C.
description OBJECTIVETo determine if survival and cognitive profile is affected by initial presentation in amyotrophic lateral sclerosis–frontotemporal dementia (ALS-FTD) (motor vs cognitive), we compared survival patterns in ALS-FTD based on initial phenotypic presentation and their cognitive profile compared to behavioral variant FTD (bvFTD). METHODSCognitive/behavioral profiles were examined in 98 patients (59 ALS-FTD and 39 bvFTD). The initial presentation of ALS-FTD was categorized into either motor or cognitive. Survival was calculated from initial symptom onset. MRI brain atrophy patterns were examined using a validated visual rating scale. RESULTSIn the ALS-FTD group, 41 (69%) patients were categorized as having an initial cognitive presentation and 18 (31%) a motor presentation. Patients with motor presentation experienced a significantly shorter median survival of 2.7 years compared to 4.4 years (p < 0.001) in those with a cognitive presentation. No differences between motor vs cognitive onset ALS-FTD were found on cognitive testing. When compared to bvFTD, ALS-FTD–cognitive presentation was characterized by reduced language function (p < 0.001), verbal fluency (p = 0.001), and naming (p = 0.007). Both motor and cognitive onset ALS-FTD showed reduced emotion processing (p = 0.01) and exhibited greater motor cortex and dorsal lateral prefrontal cortex atrophy than bvFTD. Increased motor cortex atrophy was associated with 1.5-fold reduction in survival. CONCLUSIONSInitial motor presentation in ALS-FTD leads to faster progression than in those with a cognitive presentation, despite similar overall cognitive deficits. These findings suggest that disease progression in ALS-FTD may be critically linked to physiologic and motor changes.
doi_str_mv 10.1212/WNL.0000000000009398
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_wolterskluwer_health_00006114-202005120-00009</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32277059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4348-c7c0a1169e593dcb0e9880c16ad44c3f4b8c9b42e6c0f3b59da7b5eb9c51db4b3</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhoMobk7_gUj_QObJR9vkckynQlHBid6VJE1ZtGtH0m3s39tRFfFCz825OM_zwnkROicwJpTQy5f7bAw_RjIpDtCQxDTBCaOvh2gIQAVmIhUDdBLCG0B3TOUxGjBK0xRiOUTicWHrpt2tnIk2yjulXeXaXeTqaJI94dn8KlJ1EdmytKaNmjoKa79xG1WdoqNSVcGefe4Rep5dz6e3OHu4uZtOMmw44wKb1IAiJJE2lqwwGqwUAgxJVMG5YSXXwkjNqU0MlEzHslCpjq2WJiaF5pqNEO9zjW9C8LbMV94tld_lBPJ9EXlXRP67iE676LXVWi9t8S19fd4Boge2TdVaH96r9db6fGFV1S7-y-Z_qHssIYRjChQgJhRwb34A5VV5RQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phenotypic variability in ALS-FTD and effect on survival</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Ahmed, Rebekah M. ; Devenney, Emma M. ; Strikwerda-Brown, Cherie ; Hodges, John R. ; Piguet, Olivier ; Kiernan, Matthew C.</creator><creatorcontrib>Ahmed, Rebekah M. ; Devenney, Emma M. ; Strikwerda-Brown, Cherie ; Hodges, John R. ; Piguet, Olivier ; Kiernan, Matthew C.</creatorcontrib><description>OBJECTIVETo determine if survival and cognitive profile is affected by initial presentation in amyotrophic lateral sclerosis–frontotemporal dementia (ALS-FTD) (motor vs cognitive), we compared survival patterns in ALS-FTD based on initial phenotypic presentation and their cognitive profile compared to behavioral variant FTD (bvFTD). METHODSCognitive/behavioral profiles were examined in 98 patients (59 ALS-FTD and 39 bvFTD). The initial presentation of ALS-FTD was categorized into either motor or cognitive. Survival was calculated from initial symptom onset. MRI brain atrophy patterns were examined using a validated visual rating scale. RESULTSIn the ALS-FTD group, 41 (69%) patients were categorized as having an initial cognitive presentation and 18 (31%) a motor presentation. Patients with motor presentation experienced a significantly shorter median survival of 2.7 years compared to 4.4 years (p &lt; 0.001) in those with a cognitive presentation. No differences between motor vs cognitive onset ALS-FTD were found on cognitive testing. When compared to bvFTD, ALS-FTD–cognitive presentation was characterized by reduced language function (p &lt; 0.001), verbal fluency (p = 0.001), and naming (p = 0.007). Both motor and cognitive onset ALS-FTD showed reduced emotion processing (p = 0.01) and exhibited greater motor cortex and dorsal lateral prefrontal cortex atrophy than bvFTD. Increased motor cortex atrophy was associated with 1.5-fold reduction in survival. CONCLUSIONSInitial motor presentation in ALS-FTD leads to faster progression than in those with a cognitive presentation, despite similar overall cognitive deficits. These findings suggest that disease progression in ALS-FTD may be critically linked to physiologic and motor changes.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000009398</identifier><identifier>PMID: 32277059</identifier><language>eng</language><publisher>United States: American Academy of Neurology</publisher><subject>Amyotrophic Lateral Sclerosis - complications ; Amyotrophic Lateral Sclerosis - diagnosis ; Amyotrophic Lateral Sclerosis - pathology ; Amyotrophic Lateral Sclerosis - psychology ; Atrophy - complications ; Biological Variation, Population ; Cognition Disorders - complications ; Cognition Disorders - diagnosis ; Cognition Disorders - pathology ; Female ; Frontotemporal Dementia - complications ; Frontotemporal Dementia - diagnosis ; Frontotemporal Dementia - pathology ; Frontotemporal Dementia - psychology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Motor Cortex - pathology ; Neuroimaging ; Neuropsychological Tests ; Prefrontal Cortex - pathology ; Survival Analysis</subject><ispartof>Neurology, 2020-05, Vol.94 (19), p.e2005-e2013</ispartof><rights>American Academy of Neurology</rights><rights>2020 American Academy of Neurology</rights><rights>2020 American Academy of Neurology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4348-c7c0a1169e593dcb0e9880c16ad44c3f4b8c9b42e6c0f3b59da7b5eb9c51db4b3</citedby><cites>FETCH-LOGICAL-c4348-c7c0a1169e593dcb0e9880c16ad44c3f4b8c9b42e6c0f3b59da7b5eb9c51db4b3</cites><orcidid>0000-0002-6696-1440</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32277059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Rebekah M.</creatorcontrib><creatorcontrib>Devenney, Emma M.</creatorcontrib><creatorcontrib>Strikwerda-Brown, Cherie</creatorcontrib><creatorcontrib>Hodges, John R.</creatorcontrib><creatorcontrib>Piguet, Olivier</creatorcontrib><creatorcontrib>Kiernan, Matthew C.</creatorcontrib><title>Phenotypic variability in ALS-FTD and effect on survival</title><title>Neurology</title><addtitle>Neurology</addtitle><description>OBJECTIVETo determine if survival and cognitive profile is affected by initial presentation in amyotrophic lateral sclerosis–frontotemporal dementia (ALS-FTD) (motor vs cognitive), we compared survival patterns in ALS-FTD based on initial phenotypic presentation and their cognitive profile compared to behavioral variant FTD (bvFTD). METHODSCognitive/behavioral profiles were examined in 98 patients (59 ALS-FTD and 39 bvFTD). The initial presentation of ALS-FTD was categorized into either motor or cognitive. Survival was calculated from initial symptom onset. MRI brain atrophy patterns were examined using a validated visual rating scale. RESULTSIn the ALS-FTD group, 41 (69%) patients were categorized as having an initial cognitive presentation and 18 (31%) a motor presentation. Patients with motor presentation experienced a significantly shorter median survival of 2.7 years compared to 4.4 years (p &lt; 0.001) in those with a cognitive presentation. No differences between motor vs cognitive onset ALS-FTD were found on cognitive testing. When compared to bvFTD, ALS-FTD–cognitive presentation was characterized by reduced language function (p &lt; 0.001), verbal fluency (p = 0.001), and naming (p = 0.007). Both motor and cognitive onset ALS-FTD showed reduced emotion processing (p = 0.01) and exhibited greater motor cortex and dorsal lateral prefrontal cortex atrophy than bvFTD. Increased motor cortex atrophy was associated with 1.5-fold reduction in survival. CONCLUSIONSInitial motor presentation in ALS-FTD leads to faster progression than in those with a cognitive presentation, despite similar overall cognitive deficits. These findings suggest that disease progression in ALS-FTD may be critically linked to physiologic and motor changes.</description><subject>Amyotrophic Lateral Sclerosis - complications</subject><subject>Amyotrophic Lateral Sclerosis - diagnosis</subject><subject>Amyotrophic Lateral Sclerosis - pathology</subject><subject>Amyotrophic Lateral Sclerosis - psychology</subject><subject>Atrophy - complications</subject><subject>Biological Variation, Population</subject><subject>Cognition Disorders - complications</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - pathology</subject><subject>Female</subject><subject>Frontotemporal Dementia - complications</subject><subject>Frontotemporal Dementia - diagnosis</subject><subject>Frontotemporal Dementia - pathology</subject><subject>Frontotemporal Dementia - psychology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motor Cortex - pathology</subject><subject>Neuroimaging</subject><subject>Neuropsychological Tests</subject><subject>Prefrontal Cortex - pathology</subject><subject>Survival Analysis</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LwzAUhoMobk7_gUj_QObJR9vkckynQlHBid6VJE1ZtGtH0m3s39tRFfFCz825OM_zwnkROicwJpTQy5f7bAw_RjIpDtCQxDTBCaOvh2gIQAVmIhUDdBLCG0B3TOUxGjBK0xRiOUTicWHrpt2tnIk2yjulXeXaXeTqaJI94dn8KlJ1EdmytKaNmjoKa79xG1WdoqNSVcGefe4Rep5dz6e3OHu4uZtOMmw44wKb1IAiJJE2lqwwGqwUAgxJVMG5YSXXwkjNqU0MlEzHslCpjq2WJiaF5pqNEO9zjW9C8LbMV94tld_lBPJ9EXlXRP67iE676LXVWi9t8S19fd4Boge2TdVaH96r9db6fGFV1S7-y-Z_qHssIYRjChQgJhRwb34A5VV5RQ</recordid><startdate>20200512</startdate><enddate>20200512</enddate><creator>Ahmed, Rebekah M.</creator><creator>Devenney, Emma M.</creator><creator>Strikwerda-Brown, Cherie</creator><creator>Hodges, John R.</creator><creator>Piguet, Olivier</creator><creator>Kiernan, Matthew C.</creator><general>American Academy of Neurology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-6696-1440</orcidid></search><sort><creationdate>20200512</creationdate><title>Phenotypic variability in ALS-FTD and effect on survival</title><author>Ahmed, Rebekah M. ; Devenney, Emma M. ; Strikwerda-Brown, Cherie ; Hodges, John R. ; Piguet, Olivier ; Kiernan, Matthew C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4348-c7c0a1169e593dcb0e9880c16ad44c3f4b8c9b42e6c0f3b59da7b5eb9c51db4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amyotrophic Lateral Sclerosis - complications</topic><topic>Amyotrophic Lateral Sclerosis - diagnosis</topic><topic>Amyotrophic Lateral Sclerosis - pathology</topic><topic>Amyotrophic Lateral Sclerosis - psychology</topic><topic>Atrophy - complications</topic><topic>Biological Variation, Population</topic><topic>Cognition Disorders - complications</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - pathology</topic><topic>Female</topic><topic>Frontotemporal Dementia - complications</topic><topic>Frontotemporal Dementia - diagnosis</topic><topic>Frontotemporal Dementia - pathology</topic><topic>Frontotemporal Dementia - psychology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motor Cortex - pathology</topic><topic>Neuroimaging</topic><topic>Neuropsychological Tests</topic><topic>Prefrontal Cortex - pathology</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Rebekah M.</creatorcontrib><creatorcontrib>Devenney, Emma M.</creatorcontrib><creatorcontrib>Strikwerda-Brown, Cherie</creatorcontrib><creatorcontrib>Hodges, John R.</creatorcontrib><creatorcontrib>Piguet, Olivier</creatorcontrib><creatorcontrib>Kiernan, Matthew C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Rebekah M.</au><au>Devenney, Emma M.</au><au>Strikwerda-Brown, Cherie</au><au>Hodges, John R.</au><au>Piguet, Olivier</au><au>Kiernan, Matthew C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotypic variability in ALS-FTD and effect on survival</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2020-05-12</date><risdate>2020</risdate><volume>94</volume><issue>19</issue><spage>e2005</spage><epage>e2013</epage><pages>e2005-e2013</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><abstract>OBJECTIVETo determine if survival and cognitive profile is affected by initial presentation in amyotrophic lateral sclerosis–frontotemporal dementia (ALS-FTD) (motor vs cognitive), we compared survival patterns in ALS-FTD based on initial phenotypic presentation and their cognitive profile compared to behavioral variant FTD (bvFTD). METHODSCognitive/behavioral profiles were examined in 98 patients (59 ALS-FTD and 39 bvFTD). The initial presentation of ALS-FTD was categorized into either motor or cognitive. Survival was calculated from initial symptom onset. MRI brain atrophy patterns were examined using a validated visual rating scale. RESULTSIn the ALS-FTD group, 41 (69%) patients were categorized as having an initial cognitive presentation and 18 (31%) a motor presentation. Patients with motor presentation experienced a significantly shorter median survival of 2.7 years compared to 4.4 years (p &lt; 0.001) in those with a cognitive presentation. No differences between motor vs cognitive onset ALS-FTD were found on cognitive testing. When compared to bvFTD, ALS-FTD–cognitive presentation was characterized by reduced language function (p &lt; 0.001), verbal fluency (p = 0.001), and naming (p = 0.007). Both motor and cognitive onset ALS-FTD showed reduced emotion processing (p = 0.01) and exhibited greater motor cortex and dorsal lateral prefrontal cortex atrophy than bvFTD. Increased motor cortex atrophy was associated with 1.5-fold reduction in survival. CONCLUSIONSInitial motor presentation in ALS-FTD leads to faster progression than in those with a cognitive presentation, despite similar overall cognitive deficits. These findings suggest that disease progression in ALS-FTD may be critically linked to physiologic and motor changes.</abstract><cop>United States</cop><pub>American Academy of Neurology</pub><pmid>32277059</pmid><doi>10.1212/WNL.0000000000009398</doi><orcidid>https://orcid.org/0000-0002-6696-1440</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2020-05, Vol.94 (19), p.e2005-e2013
issn 0028-3878
1526-632X
language eng
recordid cdi_wolterskluwer_health_00006114-202005120-00009
source MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Amyotrophic Lateral Sclerosis - complications
Amyotrophic Lateral Sclerosis - diagnosis
Amyotrophic Lateral Sclerosis - pathology
Amyotrophic Lateral Sclerosis - psychology
Atrophy - complications
Biological Variation, Population
Cognition Disorders - complications
Cognition Disorders - diagnosis
Cognition Disorders - pathology
Female
Frontotemporal Dementia - complications
Frontotemporal Dementia - diagnosis
Frontotemporal Dementia - pathology
Frontotemporal Dementia - psychology
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Motor Cortex - pathology
Neuroimaging
Neuropsychological Tests
Prefrontal Cortex - pathology
Survival Analysis
title Phenotypic variability in ALS-FTD and effect on survival
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T13%3A44%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotypic%20variability%20in%20ALS-FTD%20and%20effect%20on%20survival&rft.jtitle=Neurology&rft.au=Ahmed,%20Rebekah%20M.&rft.date=2020-05-12&rft.volume=94&rft.issue=19&rft.spage=e2005&rft.epage=e2013&rft.pages=e2005-e2013&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000009398&rft_dat=%3Cpubmed_cross%3E32277059%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32277059&rfr_iscdi=true